tiprankstipranks
Trending News
More News >
MacroGenics (MGNX)
NASDAQ:MGNX
US Market

MacroGenics (MGNX) Financial Statements

Compare
703 Followers

MacroGenics Financial Overview

MacroGenics's market cap is currently $113.87M. The company's EPS TTM is $0.27; its P/E ratio is -1.49; MacroGenics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 148.34M$ 57.19M$ 150.02M$ 75.64M$ 97.76M
Gross Profit$ 136.04M$ 48.97M$ 142.63M$ 72.99M$ 97.76M
Operating Income$ -110.58M$ -168.24M$ -121.42M$ -202.79M$ -131.06M
EBITDA$ -57.37M$ 2.02M$ -107.89M$ -190.86M$ -119.10M
Net Income$ -66.97M$ -9.06M$ -119.76M$ -202.12M$ -129.74M
Balance Sheet
Cash & Short-Term Investments$ 201.67M$ 229.81M$ 154.35M$ 243.62M$ 272.53M
Total Assets$ 261.65M$ 298.42M$ 289.51M$ 335.25M$ 378.74M
Total Debt$ 37.46M$ 33.97M$ 34.83M$ 25.47M$ 29.25M
Net Debt$ -145.38M$ -66.98M$ -74.05M$ -98.00M$ -151.88M
Total Liabilities$ 145.60M$ 145.81M$ 147.50M$ 95.63M$ 82.86M
Stockholders' Equity$ 116.06M$ 152.61M$ 142.01M$ 239.62M$ 295.88M
Cash Flow
Free Cash Flow$ -72.08M$ -79.97M$ -90.58M$ -150.03M$ -117.80M
Operating Cash Flow$ -68.37M$ -78.20M$ -86.96M$ -143.83M$ -111.90M
Investing Cash Flow$ 149.30M$ -80.08M$ 70.72M$ -36.61M$ -7.79M
Financing Cash Flow$ 960.00K$ 150.36M$ 1.66M$ 122.78M$ 174.34M
Currency in USD

MacroGenics Earnings and Revenue History

MacroGenics Debt to Assets

MacroGenics Cash Flow

MacroGenics Forecast EPS vs Actual EPS